Daily Stock Analysis, DGX, Quest Diagnostics Inc, priceseries

Quest Diagnostics Inc. Daily Stock Analysis
Stock Information
Open
140.09
Close
138.83
High
141.21
Low
137.66
Previous Close
142.30
Daily Price Gain
-3.47
YTD High
172.50
YTD High Date
Jan 3, 2022
YTD Low
137.66
YTD Low Date
Jan 18, 2022
YTD Price Change
-25.52
YTD Gain
-15.53%
52 Week High
174.16
52 Week High Date
Dec 31, 2021
52 Week Low
111.80
52 Week Low Date
Feb 23, 2021
52 Week Price Change
14.57
52 Week Gain
11.73%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Apr 7. 2020
81.12
May 12. 2020
105.55
24 Trading Days
30.12%
Link
LONG
Jun 30. 2020
110.83
Jul 24. 2020
122.23
17 Trading Days
10.29%
Link
LONG
Jul 27. 2021
139.35
Aug 24. 2021
148.10
20 Trading Days
6.28%
Link
LONG
Dec 2. 2021
154.32
Jan 3. 2022
166.38
21 Trading Days
7.82%
Link
Company Information
Stock Symbol
DGX
Exchange
NYSE
Company URL
http://www.questdiagnostics.com
Company Phone
9735202700
CEO
Stephen H. Rusckowski
Headquarters
New Jersey
Business Address
500 PLAZA DRIVE, SECAUCUS, NJ 07094
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001022079
About

Quest Diagnostics, Inc. is engaged in providing diagnostic testing, information and services that help patients, physicians and others to make better healthcare decisions. The company operates through two segments: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services segment comprised of two parts develops and delivers diagnostic testing, information and services to patients, physicians, health plans, hospitals, ACOs, IDNs, employers and others. It provides diagnostic information services, which includes clinical testing services such as routine testing, gene-based and esoteric testing, anatomic pathology services, as well as related services and insights. The Diagnostic Solutions includes other businesses such as risk assessment services, clinical trials testing, diagnostic products and healthcare information technology. Quest Diagnostics was founded on December 31, 1996 and is headquartered in Madison, NJ.

Description

Quest Diagnostics Incorporated provides diagnostic testing information and services in the United States and internationally. The company's Diagnostic Information Services business segment develops and delivers diagnostic testing information and services, such as routine testing, gene-based and esoteric testing, and drugs-of-abuse testing, as well as anatomic pathology services, and related services and insights. This segment offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum, and Care360 brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, and phlebotomists in physician offices. Its Diagnostic Solutions segment offers risk assessment services for the life insurance industry; and health information technology solutions for healthcare organizations and clinicians. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Madison, New Jersey.